|
|
|
|
| LEADER |
01000caa a22002652 4500 |
| 001 |
NLM147107814 |
| 003 |
DE-627 |
| 005 |
20250205103049.0 |
| 007 |
tu |
| 008 |
231223s2004 xx ||||| 00| ||chi c |
| 028 |
5 |
2 |
|a pubmed25n0490.xml
|
| 035 |
|
|
|a (DE-627)NLM147107814
|
| 035 |
|
|
|a (NLM)15009957
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a chi
|
| 100 |
1 |
|
|a Feng, Quan-zhou
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Effects of Ca2+ antagonist on cardiomyocytic apoptosis after experimental myocardial infarction
|
| 264 |
|
1 |
|c 2004
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 500 |
|
|
|a Date Completed 07.10.2004
|
| 500 |
|
|
|a Date Revised 14.09.2020
|
| 500 |
|
|
|a published: Print
|
| 500 |
|
|
|a Citation Status MEDLINE
|
| 520 |
|
|
|a OBJECTIVE: To explore the effects of Ca(2+) antagonist on apoptosis of cardiomyocytes after myocardial ischemia
|
| 520 |
|
|
|a METHODS: The model of myocardial infarction was made by ligating left coronary artery in SD rats. In experimental group, the rats were administrated with Adalat through oral cavity (1 mg/kg) before operation and through peritoneal cavity (0.4 mg/kg 3 hours after operation. In ischemic control group the rats were injected with placebo and in normal control group the rats were treated with sham operation (no ligating left coronary artery) and placebo. The rats were killed 6 hours after operation, with their left ventricular function had been measured. Apoptotic myocardial cells were detected by terminal deoxynucleotidyl transferase mediated dUTP nick end-labeling (TUNEL) method, Fas and Bcl-2 proteins by the ABC immunohistochemistry method. Apoptosis indexes were calculated under high magnification field of microscopy
|
| 520 |
|
|
|a RESULTS: The systolic pressure, end-diastolic pressure and dp/dt of left ventricle in experiment group were not significant different from those in the ischemic control group, they were 76.7+/-7.5/8.0+/-6.1 mm Hg vs. 74.9+/-11.1/11.6+/-8.3 mm Hg (P>0.05) and (777.3+/-128.6)mm Hg/s vs. (761.8+/-136.4)mm Hg/s (P>0.05) respectively; but those in both the experimental group and the ischemic control group were lower than those in the normal control group, they were 94.9+/-7.5/2.8+/-3.2 mm Hg (P<0.001) and (1131.5+/-112.8)mm Hg/s(P<0.001). There were a lot of positive myocytes with TUNEL stain in the ischemic region of left ventricle in both the experimental and the ischemic control group, apoptosis index in the experimental group was lower than that in the ischemic control group (0.201+/-0.053 vs. 0.261+/-0.045, P<0.05). The positive myocytes of Fas and Bcl-2 protein appeared in the region surrounding ischemic myocytes. There were no positive myocytes with the three types of stain in normal control group
|
| 520 |
|
|
|a CONCLUSION: Ischemia could induce apoptosis of myocytes and expression of Fas and Bcl-2 gene; Ca(2+) antagonist could protect myocytes from apoptosis
|
| 650 |
|
4 |
|a Comparative Study
|
| 650 |
|
4 |
|a Journal Article
|
| 650 |
|
4 |
|a Research Support, Non-U.S. Gov't
|
| 650 |
|
7 |
|a Calcium Channel Blockers
|2 NLM
|
| 650 |
|
7 |
|a Fas protein, rat
|2 NLM
|
| 650 |
|
7 |
|a Proteins
|2 NLM
|
| 650 |
|
7 |
|a Proto-Oncogene Proteins c-bcl-2
|2 NLM
|
| 650 |
|
7 |
|a Receptors, Tumor Necrosis Factor
|2 NLM
|
| 650 |
|
7 |
|a fas Receptor
|2 NLM
|
| 650 |
|
7 |
|a Nifedipine
|2 NLM
|
| 650 |
|
7 |
|a I9ZF7L6G2L
|2 NLM
|
| 700 |
1 |
|
|a Li, Tian-de
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Wang, Zhao-xia
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Yi, Jun
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Wang, Li
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Yang, Ting-shu
|e verfasserin
|4 aut
|
| 773 |
0 |
8 |
|i Enthalten in
|t Zhongguo wei zhong bing ji jiu yi xue = Chinese critical care medicine = Zhongguo weizhongbing jijiuyixue
|d 1998
|g 16(2004), 3 vom: 01. März, Seite 133-6
|w (DE-627)NLM098227793
|x 1003-0603
|7 nnns
|
| 773 |
1 |
8 |
|g volume:16
|g year:2004
|g number:3
|g day:01
|g month:03
|g pages:133-6
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_350
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 16
|j 2004
|e 3
|b 01
|c 03
|h 133-6
|